51,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Over the last decade, interest in the use of imaging technologies during radiotherapy has increased dramatically as the need for minimizing geometric uncertainties during highly conformal radiation deliveries became apparent. Due to this, many innovative in-room imaging technologies for treatment guidance has been developed and translated in to daily clinical use. However, with this rise in interest has also sparked the need to evaluate and understand the optimal use of such technologies for cancer treatment. With a focus on prostate cancer as an example, this book therefore aims to provide…mehr

Produktbeschreibung
Over the last decade, interest in the use of imaging
technologies during radiotherapy has increased
dramatically as the need for minimizing geometric
uncertainties during highly conformal radiation
deliveries became apparent. Due to this, many
innovative in-room imaging technologies for treatment
guidance has been developed and translated in to
daily clinical use. However, with this rise in
interest has also sparked the need to evaluate and
understand the optimal use of such technologies for
cancer treatment. With a focus on prostate cancer as
an example, this book therefore aims to provide the
audience with systematic evaluation of various
technologies used during radiotherapy for treatment
guidance. Using modern evaluation tools such as
deformable image registration, convolution, and
radiobiologic indices, the potential benefits of
in-room imaging technologies during radiotherapy is
demonstrated. The analysis should help shed some
light on the useful techniques and benefits of using
new and exciting imaging technologies for radiation
treatments of cancer.
Autorenporträt
William Y. Song, PhD: Obtained PhD in Medical Biophysics at the
University of Western Ontario, London, Canada. Currently an
Assistant Professor and Medical Physicist in Radiation Oncology
at the University of California, San Diego, California, USA.